Concepedia

Author

David P. Kelsen

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

D KELSEN, D Kelsen, D P Kelsen, D. Kelsen, D. P. Kelsen, D.P. KELSEN, D.P. Kelsen, DAVID P. KELSEN, David Kelsen, David P Kelsen

493

Publications

22.6K

Citations

87

H-Index

118

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterCornell UniversityNational Cancer Institute
DP

About

David P. Kelsen is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

45

98

8.2K

2

Health Sciences

16

23

2.1K

3

Engineering

3

3

171

4

Natural Sciences

1

1

36

5

Biomedical Engineering

1

1

36

David P. Kelsen

×

211

Publications

20.6K

Citations

82

H-Index

YearCitations

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, Han Sang Kim, Linda Bojmar,

Cell

2020

1.2K

Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

Ki Y. Chung, Jinru Shia, Nancy E. Kemeny,

Journal of Clinical Oncology

2005

1.1K

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen,

Investigational New Drugs

1994

440

Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Manish A. Shah, Ramesh K. Ramanathan, David H. Ilson,

Journal of Clinical Oncology

2006

409

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

Farid Fata, Eileen M. O’Reilly, David H. Ilson,

Cancer

1999

387

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline <i>BRCA/PALB2</i> Mutation

Eileen M. O’Reilly, Jonathan W. Lee, Mark M. Zalupski,

Journal of Clinical Oncology

2020

383

Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

Yelena Y. Janjigian, Francisco Sánchez-Vega, Philip Jonsson,

Cancer Discovery

2017

373

Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules

Richard J. Gralla, Ephraim S. Casper, David P. Kelsen,

Annals of Internal Medicine

1981

366

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

Yelena Y. Janjigian, Dominique Werner, Claudia Pauligk,

Annals of Oncology

2012

359

Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations

Zishuo I. Hu, Jinru Shia, Zsofia K. Stadler,

Clinical Cancer Research

2018

353

Page 1